This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Mannheim Gmbh. Active years: 1995.
Company Filing History:
Years Active: 1995
Title: The Innovations of Charles E. Durant
Introduction
Charles E. Durant is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on maleimide adduct conjugates. His research has led to the development of novel derivatives of procainamide and N-acetylprocainamide (NAPA).
Latest Patents
Charles E. Durant holds 1 patent for his invention titled "Maleimide adduct conjugates of procainamide and NAPA." This patent discloses novel derivatives of procainamide and N-acetylprocainamide (NAPA) characterized by a specific chemical formula. His work in this area has the potential to impact therapeutic applications significantly.
Career Highlights
Durant is associated with Boehringer Mannheim GmbH, where he has been able to apply his expertise in pharmaceutical innovation. His role at the company has allowed him to contribute to advancements in drug development and formulation.
Collaborations
Throughout his career, Charles E. Durant has collaborated with esteemed colleagues such as Gerald F. Sigler and Charles F. Walter. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Charles E. Durant's contributions to the field of pharmaceuticals through his patent on maleimide adduct conjugates exemplify the importance of innovation in medicine. His work continues to inspire advancements in drug development and therapeutic solutions.